Clinical Trial

Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)

Name: Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE) — clinical trial record (NCT06791772)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of CM313(SC) injection in systemic lupus erythematosus(SLE)

Trial Details

NCT Number	NCT06791772
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Systemic Lupus Erythematosus
Enrollment	150 participants
Start Date	2025-02
Primary Completion	2026-10 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2025-01-24